TREX1 counteracts potential cGAS-STING induction in the TME and thereby the anti-tumor immune response by degrading tumor-derived DNA that is either spontaneously generated or induced by DNA damaging therapeutic approaches (156). Here, CGAS is linked to neoplasm.